Dr. Harin Haridas Kanani has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
NEOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Harin Haridas Kanani, a Promoter of Neogen Chemicals Limited, has submitted an annual disclosure to the stock exchanges under SEBI Regulation 31(4). In the filing dated April 4, 2025, he confirms that there has been no creation, invocation, or release of any encumbrance (pledge/lien) on shares of Neogen Chemicals held by him and persons acting in concert with him during the financial year ended March 31, 2025. This is a routine annual compliance submission required from promoters. No change in the pledged status of promoter shares is being reported.
This is a neutral-to-slightly positive compliance filing, as it confirms the promoter has not added new pledges or released existing ones on Neogen shares during FY25, meaning no incremental financial stress signal from the promoter group for shareholders.